
Hillcrest Energy Technologies. (CSE: HEAT)
From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future.
Growth investing is making a comeback in 2024, but the top picks aren’t limited to the tech sector. The energy sector is soaring, and so is CES Energy Solutions If you have $5,000 to invest, these two stocks are some of the best growth stocks available. As the interest rate cut cycle approaches, the investment climate will improve and these two stocks will return far better than their current market performance.
CES Energy is a $1.8 billion market cap oil and gas company that produces advanced depletion fluids and provides specialty chemical solutions for the full life cycle of oil fields for customers in the United States and Canada. In terms of performance, this small-cap energy stock is up 123% year to date. Additionally, at a price of $7.61 per share, the overall return over three years is 348.5%. The stock also pays a 1.6% dividend. Market analysts recommend a “Buy to Strong Buy” rating.
The company’s two core business segments are drilling fluids and specialty chemicals. In the first quarter of 2024, the company reported revenues of $588.6 million, a 6% increase from the first quarter of 2023, and net income of $54.4 million, a 65% increase from the same period last year. Free cash flow (FCF) reached $57.4 million, up 278% from the same period last year, due to strong financial performance, solid activity levels and higher contribution margins.
Healwell AI’s upward momentum is unstoppable. Priced at just $2.45 per share, this growth stock has risen 228.7% since the end of 2023. WELL Health Technologies (TSX: WELL), Canada’s largest owner and operator of outpatient health clinics, is a strategic partner of the company. Healwell AI is currently in the red, but has already started to turn a profit. “We are incredibly optimistic about our future trajectory, driven by a combination of organic growth and strategic acquisitions”, said Dr Alexander Dobranowski, the company’s CEO.